Tower Research Capital (TRC)’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58K | Buy |
2,957
+585
| +25% | +$708 | ﹤0.01% | 4473 |
|
|
2025
Q1 | $3.3K | Buy |
2,372
+1,785
| +304% | +$2.48K | ﹤0.01% | 4436 |
|
|
2024
Q4 | $3.15K | Sell |
587
-571
| -49% | -$3.07K | ﹤0.01% | 4701 |
|
|
2024
Q3 | $8.23K | Buy |
1,158
+394
| +52% | +$2.8K | ﹤0.01% | 3973 |
|
|
2024
Q2 | $7.17K | Sell |
764
-54
| -7% | -$507 | ﹤0.01% | 4491 |
|
|
2024
Q1 | $12.3K | Sell |
818
-27
| -3% | -$405 | ﹤0.01% | 3493 |
|
|
2023
Q4 | $16.5K | Buy |
845
+204
| +32% | +$3.98K | ﹤0.01% | 3779 |
|
|
2023
Q3 | $22.9K | Buy |
641
+86
| +15% | +$3.07K | ﹤0.01% | 3253 |
|
|
2023
Q2 | $28.1K | Sell |
555
-387
| -41% | -$19.6K | ﹤0.01% | 3063 |
|
|
2023
Q1 | $24K | Buy |
942
+288
| +44% | +$7.34K | ﹤0.01% | 3234 |
|
|
2022
Q4 | $21K | Buy |
654
+143
| +28% | +$4.59K | ﹤0.01% | 3080 |
|
|
2022
Q3 | $32K | Buy |
511
+456
| +829% | +$28.6K | ﹤0.01% | 3541 |
|
|
2022
Q2 | $9K | Buy |
55
+28
| +104% | +$4.58K | ﹤0.01% | 4549 |
|
|
2022
Q1 | $7K | Buy |
+27
| New | +$7K | ﹤0.01% | 4715 |
|
|
2021
Q4 | – | Sell |
-5
| Closed | -$7K | – | 6236 |
|
|
2021
Q3 | $7K | Sell |
5
-2
| -29% | -$2.8K | ﹤0.01% | 4635 |
|
|
2021
Q2 | $12K | Buy |
+7
| New | +$12K | ﹤0.01% | 4273 |
|